NCT02603185View on ClinicalTrials.gov

PhaseⅠFirst-in-Human Study of Hemay007 in Healthy Volunteers

PHASE1UnknownINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

January 9, 2017

Primary Completion Date

March 31, 2018

Study Completion Date

March 31, 2018

Conditions
Inflammatory Bowel Disease
Interventions
DRUG

Hemay007

DRUG

placebo

Trial Locations (1)

5000

RECRUITING

CMAX Clinical Research Pty Ltd, Adelaide

Sponsors
All Listed Sponsors
collaborator

Tianjin Hemay Pharmaceutical Co., Ltd

INDUSTRY

lead

Hemay Pharmaceutical PTY. LTD.

INDUSTRY